FindTrial
Sign In

Comparison of the efficacy and safety of drugs or splenectomy in the treatment of primary Immune thrombocytopenia: a clinical retrospective cohort study

Comparison of the efficacy and safety of drugs or splenectomy in the treatment of primary Immune thrombocytopenia: a clinical retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076101
Enrollment
Unknown
Registered
2023-09-25
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Immune thrombocytopenia

Interventions

Splenectomy group:N/A
Medicine group:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: diagnosed as primary ITP

Exclusion criteria

Exclusion criteria: 1) secondary ITP; 2) pregnancy; 3) malignant tumor.

Design outcomes

Primary

MeasureTime frame
Survival;Curative effect;—

Secondary

MeasureTime frame
Postoperative complications;Total postoperative hospitalization days;Recurrence;Long term complications;Baseline information;—

Countries

China

Contacts

Public ContactNiu Ting

West China Hospital, Sichuan University

tingniu@sina.com+86 189 8060 1242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026